Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.96 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.96 |
| ▸ | KDM6A | O15550 | 1/20 | 0.96 |
| ▸ | KDM4A | O75164 | 1/20 | 0.96 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.96 |
| ▸ | KDM5C | P41229 | 1/20 | 0.96 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.96 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.96 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.96 |
| ▸ | COMT | P21964 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 3/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP7 | P09237 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deferiprone SCHEMBL20775057 | 0.98 | KDM4E (1.00) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL94474 | 0.98 | KDM4E (1.00) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28363784 | 0.96 | KDM4E (0.96) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL10464107 | 0.96 | KDM4E (0.96) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28536949 | 0.85 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL28405012 | 0.85 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL6400926 | 0.85 | KDM4E (0.76) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL7224598 | 0.80 | KDM4E (0.67) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL4951162 | 0.79 | KDM4E (0.65) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 | |
| Deferiprone SCHEMBL9075381 | 0.78 | KDM4E (0.63) | KDM4ECYP2C19KDM6AKDM4ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101102762-A | Compositions including iron | DRUGTECH CORP (US) | 2008-01-09 | — | — | CN | claimed |
| EP-1827419-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| EP-1827418-A2 | COMPOSITIONS INCLUDING IRON | Drugtech Corporation (US) | 2007-09-05 | — | — | EP | claimed |
| WO-2006068697-A2 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2006068729-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060134227-A1 | Compositions including iron | DRUGTECH CORPORATION | 2006-06-22 | — | — | US | claimed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | claimed |
| WO-2023119230-A1 | COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| US-20220160830-A1 | COMPOSITIONS COMPRISING CHOLINE | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-05-26 | — | — | US | disclosed |
| CN-114073772-A | Use of an iron chelator for the treatment or prevention of polyoma viral infections | 上海市公共卫生临床中心 | 2022-02-22 | — | — | CN | disclosed |
| US-20210179695-A1 | NOVEL FUNGAL TOXINS AND METHODS RELATED TO THE SAME | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER | 2021-06-17 | — | — | US | disclosed |
| CN-112672786-A | Hinokitiol analogue, preparation method and pharmaceutical composition thereof | 伊利诺伊大学评议会 | 2021-04-16 | — | — | CN | disclosed |
| US-10877037-B2 | Fungal toxins and methods related to the same | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2020-12-29 | — | — | US | disclosed |
| WO-2006055412-A1 | METHODS OF TREATING ERYTHROPOIETIN-RESISTANCE | SHIVA BIOMEDICAL, LLC (US) | 2006-05-26 | — | — | WO | disclosed |
| WO-2005120524-A2 | NUTRITIONAL FORMULATIONS | DRUGTECH CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |
| US-20050037065-A1 | NUTRITIONAL FORMULATIONS | DRUGTECH CORPORATION (US) | 2005-02-17 | — | — | US | disclosed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | disclosed |
| US-5051523-A | Transcomplexing a complex of a beta-dicarbonyl metal with a chelating agent | CIBA-GEIGY CORPORATION (US) | 1991-09-24 | — | — | US | disclosed |